Evolent Health Balance Sheet Health
Financial Health criteria checks 4/6
Evolent Health has a total shareholder equity of $1.2B and total debt of $597.0M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are $2.7B and $1.4B respectively. Evolent Health's EBIT is $30.8M making its interest coverage ratio 0.6. It has cash and short-term investments of $192.8M.
Key information
47.9%
Debt to equity ratio
US$597.05m
Debt
Interest coverage ratio | 0.6x |
Cash | US$192.83m |
Equity | US$1.25b |
Total liabilities | US$1.43b |
Total assets | US$2.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 9EH's short term assets ($683.7M) exceed its short term liabilities ($674.2M).
Long Term Liabilities: 9EH's short term assets ($683.7M) do not cover its long term liabilities ($759.9M).
Debt to Equity History and Analysis
Debt Level: 9EH's net debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: 9EH's debt to equity ratio has increased from 18.6% to 47.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 9EH has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 9EH is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 33.1% per year.